NEXGEL, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Description of Business, Stock Split and Basis of Presentation (Details Narrative)

Description of Business, Stock Split and Basis of Presentation (Details Narrative)	Mar. 01, 2023	Jan. 06, 2023
Joint Venture [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition percentage	50.00%
CG Labs [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition percentage	50.00%
Enigma Health Joint Venture [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition percentage		50.00%
Moiety [Member]
Restructuring Cost and Reserve [Line Items]
Acquisition percentage		50.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details